The senior leadership team at Triangle Insights has deep experience in life sciences strategy.

Brendan Smith has over five years of experience in the life science industry, particularly in molecular diagnostic research and development. During his doctoral studies, Brendan developed novel reverse genetics techniques to investigate respiratory virus evolution and its impact on viral fitness and immune evasion. Brendan’s recent engagements at Triangle Insights have included commercial landscape assessments, competitive strategy, due diligence, revenue forecasting, and search-based opportunity identification.

His experience spans a range of therapeutic areas, including oncology, rheumatology, CNS, infectious disease, and women’s health.​

Degrees: Ph.D., Molecular Microbiology and Immunology, Johns Hopkins University | B.S., Chemistry, University of North Carolina at Greensboro

Nick Toombs is an experienced consultant who has supported clients in a wide range project types and therapeutic areas. He has focused on commercial assessment, portfolio strategy, and new product planning engagements, and has worked with clients ranging from large biopharmaceutical organizations to preclinical biotechs.

Prior to joining Triangle, Nick worked with Pfizer in their Global Pricing group, focusing on oncology and rare disease in Internationally Developed Markets. His educational background is in economics, with a concentration on pharmaceutical and healthcare markets.​

Degrees: B.A., Economics, University of North Carolina at Chapel Hill

Meghna Shankar is an Engagement Manager at Triangle Insights bringing five years of experience in the life science industry with a focus on pricing and market access. Her recent engagements have focused on payer research, pricing and GTN strategy, and policy-impact modeling in response to the IRA. Meghna also has broad experience in commercial landscape assessments, primary market research, corporate strategy, and due diligence across a range of therapeutic areas, including oncology, rare disease, digital therapeutics, and women’s health.

Prior to joining Triangle, Meghna held roles in marketing and product management at ThermoFisher Scientific, overseeing their stem cell culture product portfolio, and genetic research at the University of Virginia Aging & Obesity Institute.​

Degrees: B.A., Biology; Minor, Business | University of Virginia

Mahima Bhatt is an Engagement Manager at Triangle Insights with an educational background in microbiology, immunology, and molecular genetics and global health. Her prior experience includes molecular parasitology research and microbiology research at UCLA. Since joining Triangle Insights Group, Mahima’s engagements have included commercial opportunity assessment, portfolio prioritization, and commercial due diligence. She also has deep experience conducting primary research across a wide variety of stakeholders, project types, and therapeutic areas ranging from CNS to oncology.​

Degrees: B.S., Microbiology, Immunology, and Molecular Genetics; Minor, Global Health | University of California, Los Angeles

Rob Glowacki is a Senior Engagement Manager at Triangle Insights. He practiced law in North Carolina with a focus on business litigation and commercial transactions before earning his MBA with a certificate in Health Sector Management. Rob’s recent engagements include value proposition development, target product profile (TPP) optimization, patient journey and segmentation analysis, commercial assessments, ATU studies, and corporate strategy. His work spans therapeutic areas such as dermatology, oncology, CNS, and cardiometabolic disease.​

Degrees: M.B.A., Fuqua School of Business at Duke University| J.D., University of North Carolina-Chapel Hill | B.A., Economics, Clemson University

Emily Hoffman has over 8 years of experience in life sciences consulting.​

Since joining Triangle Insights, her engagements have involved indication prioritization, opportunity assessments, workshop facilitation, corporate strategy, and new product planning for various therapeutic areas including oncology, immunology, and rare disease.

Prior to joining Triangle Insights, Emily worked at CEEK Enterprises (now TwoLabs) and Charles River Associates Life Sciences practice.​

Degrees: Degrees: PhD, Engineering, Northwestern University | B.S., Biomedical Engineering, Case Western Reserve University​

Michael Turner has over 25 years of commercial strategy consulting experience in life sciences. He serves as an advisor to commercial leaders in development, commercialization, launch, and competitive strategy. ​

Throughout his career, he has supported the commercialization of over 75 global launch products across most therapeutic areas, as well as complex specialty products and cell & gene therapy. Additionally, Michael has supported many emerging global biopharmaceutical companies to prepare for their first U.S. product launch.​

Previously, he has been a Partner at several global strategy consulting firms, including LifeSci Consulting, Campbell Alliance and Blue Fin Group.​

Degrees: B.S., Operations Research and Engineering, Cornell University’s College of Engineering; MBA, University of Michigan’s Ross School of Business

Jennifer (Jen) Greeby is an experienced biotech executive and strategy consultant with over 25 years leading commercial growth across the product life-cycle. Jen has significant background in leading pricing, value, and access engagements as well as new product planning and commercial launch strategy and execution. She has supported and led numerous launches across complex, heavily managed therapeutic markets inclusive of oncology, rare disease, diabetes, obesity, renal and hematology, among others.

Prior to joining Triangle Insights, she spent several years consulting focused on launch excellence for early-stage assets and portfolios, and prior to that, in US and Global brand and franchise leadership roles at Athenex Oncology, Shire/Baxalta, and Takeda.​

Degrees: MBA, Univ. of Michigan; B.S., Industrial and Chemical Engineering, Univ. of Cincinnati

Jackie Davi is a knowledgeable strategy consultant with experience across various therapeutic areas (e.g., dermatology, psychiatry, neurology). During her time at Triangle, Jackie has been engaged in projects focusing on launch strategy, commercial assessment, market research, and portfolio strategy. Prior to joining Triangle Insights, she spent time doing academic research in cell biology and physiology at the UNC Chapel Hill School of Medicine. Jackie has academic experience in medical device creation and regulation. ​

Degrees: B.S., Biomedical Engineering, University of North Carolina-Chapel Hill

Kyle Wolpert has held roles in commercial operations, finance, and research functions across a decade of experience in the life sciences. While pursuing his M.B.A. at Fuqua, he worked closely with start-up founders to support new ventures developing RNA vaccines, small molecule therapeutics, and other innovative technologies. Areas of focus in his recent engagements at Triangle Insights include diligence of research and manufacturing technologies, commercial assessments of novel cellular therapies, and market access strategies in the US and EU.​

Degrees: M.B.A., Fuqua School of Business at Duke University | B.A., Biological Sciences, Cornell University

Vaibhav Shrishail is an experienced life sciences professional with experience in an array of project types and therapeutic areas. Since joining Triangle Insights, his engagements have involved workshop facilitation, corporate strategy, indication prioritization, and new product planning for various therapeutic areas including cardiology, oncology, neurology, and rare disease.

His prior work experience includes medical device design for United Therapeutics as well as innovation consulting for digital health technologies at RTI International. During his time at UNC Chapel Hill, he double majored in biology and chemistry with a minor in entrepreneurship. He also conducted research in metabolomics and medical device design for multiple years at the UNC School of Medicine.​

Degrees: B.S., Biology; B.A., Chemistry | University of North Carolina at Chapel Hill

Matt is an experienced consulting manager who helps to shape PMA thought leadership at Triangle and develop go-to-market and revenue preservation strategies, portfolio- and account-level forecasting, and policy-impact modeling (e.g.., IRA). Recent engagements have explored reimbursement for cell therapies and critical-care COVID-19 treatments, first-in-indication launch strategy development in the CNS space, claims-based analysis of UM approaches, and life-cycle management across both generic/biosimilar entrants and parent brands.

Matt also brings scientific expertise to the Triangle team, with a competitively-funded academic background spanning medical device design, nanotechnology development, and professional education in addition to BD and commercial strategy roles.​

Degrees: Ph.D., Pharmaceutical Sciences, University of North Carolina-Chapel Hill | B.S., Biomedical Engineering, Johns Hopkins University